Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries

8 August 2023 - Managed entry agreements continue to emerge in health technology assessment based decision-making, to address evidentiary uncertainties arising ...

Read more →

Efficient funding of chemotherapy review - submissions on discussion paper

18 June 2021 - The efficient funding of chemotherapy review discussion paper was released on 21 May 2021 to gain ...

Read more →

Agenda for the November 2020 PBAC meeting

26 August 2020 - The agenda for the November 2020 PBAC meeting is now available. ...

Read more →

Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC—does the presence of an explicit threshold affect the ICER proposed?

8 August 2018 - The English NICE and the Australian PBAC require evidence that a new medicine represents value for money ...

Read more →

PBAC post-market reviews of chronic obstructive pulmonary disease medicines and ezetimibe

5 August 2016 - The public submission process is now closed. ...

Read more →

Expanded PBS Safety Net early supply arrangements apply from 1 January 2016

4 January 2016 - Measures announced as part of the PBS Access and Sustainability package include expanding Safety Net early supply ...

Read more →

Meet the health crusader saving lives with cheap drugs

20 August 2015 - A Tasmanian man with hepatitis C is taking on a global pharmaceutical company for what he says ...

Read more →